Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactions

被引：4

作者：

Fuchs, EJ ^{[1
]}

Seber, A ^{[1
]}

Altomonte, V ^{[1
]}

Braine, HG ^{[1
]}

Humphrey, RL ^{[1
]}

Jones, RJ ^{[1
]}

Noga, SJ ^{[1
]}

Schepers, K ^{[1
]}

Wright, SK ^{[1
]}

Vogelsang, GB ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med,Bone Marrow Transplantat Program, Johns Hopkins Oncol Ctr, Div Hematol Malignancies, Baltimore, MD 21205 USA

来源：

BONE MARROW TRANSPLANTATION | 1998年 / 22卷 / 03期

关键词：

multiple myeloma; bone marrow transplantation; leukocyte transfusions; chemotherapy; graft-versus-myeloma; graft-versus-host disease;

D O I：

10.1038/sj.bmt.1701323

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

Two patients with multiple myeloma in relapse after allogeneic BMT received donor lymphocyte infusions (DLI) but later required chemotherapy for treatment of myeloma-related complications. In both patients, recovery from chemotherapy-induced aplasia was accompanied by manifestations of graft-versus-host reactions. The first patient developed grade II acute GVHD and a complete remission which has lasted >22 months. The second patient developed grade III acute GVHD but died with co-existing GVHD and extensive extramedullary myeloma, These results demonstrate that chemotherapy does not nullify the ability of donor lymphocytes to mediate graft-versus-host reactions.

引用

页码：303 / 305

页数：3

共 11 条

[1] BUTTURINI A, 1986, BLOOD, V68, P954
[2] Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
Collins, RH
Shpilberg, O
Drobyski, WR
Porter, DL
Giralt, S
Champlin, R
Goodman, SA
Wolff, SN
Hu, W
Verfaillie, C
List, A
Dalton, W
Ognoskie, N
Chetrit, A
Antin, JH
Nemunaitis, J
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 433 - 444
[3] GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS
KOLB, HJ
SCHATTENBERG, A
GOLDMAN, JM
HERTENSTEIN, B
JACOBSEN, N
ARCESE, W
LJUNGMAN, P
FERRANT, A
VERDONCK, L
NIEDERWIESER, D
VANRHEE, F
MITTERMUELLER, J
DEWITTE, T
HOLLER, E
ANSARI, H
[J]. BLOOD, 1995, 86 (05) : 2041 - 2050
[4] Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation
Lokhorst, HM
Schattenberg, A
Cornelissen, JJ
Thomas, LLM
Verdonck, LF
[J]. BLOOD, 1997, 90 (10) : 4206 - 4211
[5] ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE
MACKINNON, S
PAPADOPOULOS, EB
CARABASI, MH
REICH, L
COLLINS, NH
BOULAD, F
CASTROMALASPINA, H
CHILDS, BH
GILLIO, AP
KERNAN, NA
SMALL, TN
YOUNG, JW
OREILLY, RJ
[J]. BLOOD, 1995, 86 (04) : 1261 - 1268
[6] RELAPSE OF ACUTE-LEUKEMIA AFTER MARROW TRANSPLANTATION - NATURAL-HISTORY AND RESULTS OF SUBSEQUENT THERAPY
MORTIMER, J
BLINDER, MA
SCHULMAN, S
APPELBAUM, FR
BUCKNER, CD
CLIFT, RA
SANDERS, JE
STORB, R
THOMAS, ED
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 50 - 57
[7] CD34(+) stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine a is still required to reduce GVHD and morbidity
Noga, SJ
Vogelsang, GB
Seber, A
Davis, JM
Schepers, K
Hess, AD
Jones, RJ
[J]. TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 728 - 732
[8] Porter D., 1997, Blood, V90, p384B
[9] STORB R, 1971, J IMMUNOL, V107, P409
[10] MARROW TRANSPLANTATION FOR TREATMENT OF APLASTIC-ANEMIA - ANALYSIS OF FACTORS ASSOCIATED WITH GRAFT REJECTION
STORB, R
PRENTICE, RL
THOMAS, ED
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (02) : 61 - 66

← 1 2 →